PRTA

Prothena (PRTA)

Prothena Corporation PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PRTA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/04	09:45	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:PRTA	Prothena Corporation PLC
2024/12/31	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/12/31	06:05	Business Wire	Prothena Announces Board of Directors Update	NASDAQ:PRTA	Prothena Corporation PLC
2024/12/19	15:05	Business Wire	Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/13	21:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/13	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/13	06:05	Business Wire	Prothena Reports Third Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/06	06:05	Business Wire	Prothena to Report Third Quarter 2024 Financial Results on November 12	NASDAQ:PRTA	Prothena Corporation PLC
2024/10/04	07:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/10/04	07:57	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/09/28	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/09/28	05:05	Business Wire	Prothena Announces Leadership Team Updates	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/30	05:05	Business Wire	Prothena to Participate in Upcoming Healthcare Conferences	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	06:13	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	05:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	05:05	Business Wire	Prothena Reports Second Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/02	05:05	Business Wire	Prothena to Report Second Quarter 2024 Financial Results on August 8	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/29	05:05	Business Wire	Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05:19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05:05	Business Wire	Prothena Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/02	05:05	Business Wire	Prothena to Report First Quarter 2024 Financial Results on May 8	NASDAQ:PRTA	Prothena Corporation PLC
2024/04/16	05:05	Business Wire	Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	11:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	11:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC